ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

19,606Medicare Part D Prescriptions Filled, Including Refills

Rank: 60 out of 1121

$1.01M Total Retail Price of All Prescriptions

Rank: 71 out of 1121

957 Patients Receiving at Least One Drug in Part D
92%Patients 65 Years and Older
14% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Tennessee
Lower avg

Schedule Two
Controlled Substances

1% of this provider’s 957 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

8% of this provider’s 957 patients filled at least one prescription for a schedule three drug, compared to an average of 15%.

Risky Drugs to Seniors

3% of this provider’s 18,174 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

26% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$51 was the average price of a prescription from this provider, compared to $55 among peers.

Prescriptions per Patient

20 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Tennessee
SIMVASTATIN 929 899 1 1
AMLODIPINE BESYLATE 803 767 2 5
ATENOLOL 611 583 3 16
LEVOTHYROXINE SODIUM 610 580 4 2
FUROSEMIDE 550 494 5 7
OMEPRAZOLE 527 509 6 6
HYDROCHLOROTHIAZIDE 384 361 7 10
TRIAMTERENE-HCTZ 382 349 8 38
HYDROCODONE-ACETAMINOPHEN 376 335 S3 9 3
MELOXICAM 360 321 10 22
LISINOPRIL 359 319 11 4
METFORMIN HCL 315 289 12 8
POTASSIUM CHLORIDE 299 277 13 12
LOSARTAN POTASSIUM 294 257 14 17
AZITHROMYCIN 288 275 15 44
ALLOPURINOL 286 274 16 30
METOPROLOL SUCCINATE 275 261 17 23
PRAVASTATIN SODIUM 272 243 18 14
ZOLPIDEM TARTRATE 264 249 19 19
GABAPENTIN 260 221 20 13
ATORVASTATIN CALCIUM 257 248 21 15
METOPROLOL TARTRATE 255 231 22 9
CITALOPRAM HBR 246 209 23 18
WARFARIN SODIUM 237 233 24 11
SERTRALINE HCL 234 215 25 21
LISINOPRIL-HYDROCHLOROTHIAZIDE 234 233 25 31
BENAZEPRIL HCL 229 191 27 41
NEXIUM 222 212 28 24
TAMSULOSIN HCL 211 209 29 32
LOSARTAN-HYDROCHLOROTHIAZIDE 180 170 30 46
TRAZODONE HCL 172 140 31 40
KLOR-CON 10 164 145 32 69
ALENDRONATE SODIUM 161 161 33 37
SPIRONOLACTONE 161 144 33 54
TRAMADOL HCL 158 129 35 25
CRESTOR 157 157 36 28
SYNTHROID 150 142 37 55
FLUTICASONE PROPIONATE 149 142 38 36
CYMBALTA 149 126 38 50
CARVEDILOL 145 136 40 20
CLOPIDOGREL 141 138 41 27
DONEPEZIL HCL 135 135 42 35
GLIMEPIRIDE 134 134 43 34
CIPROFLOXACIN HCL 132 117 44 57
LIPITOR 122 122 45 106
CLONIDINE HCL 117 107 46 39
METHYLPREDNISOLONE 109 104 47 97
HYDRALAZINE HCL 108 105 48 66
JANUMET 104 100 49 167
PLAVIX 104 93 49 42
OXYBUTYNIN CHLORIDE 97 89 51 128
LANSOPRAZOLE 92 69 52 162
DIGOXIN 92 90 52 59
PAROXETINE HCL 89 81 54 58
ZETIA 88 88 55 80
GLYBURIDE 88 88 R 55 51
ESCITALOPRAM OXALATE 87 87 57 94
FLUOXETINE HCL 82 82 58 60
CHLORZOXAZONE 81 81 R 59 382
JANUVIA 79 79 60 81
FELODIPINE ER 77 77 61 169
NAMENDA 72 72 62 53
DOXYCYCLINE HYCLATE 72 71 62 103
SINGULAIR 70 70 64 78
VERAPAMIL ER 69 69 65 89
DIOVAN HCT 67 56 66 90
DIOVAN 67 64 66 45
BYSTOLIC 63 48 68 121
AMLODIPINE BESYLATE-BENAZEPRIL 62 62 69 65
AMITRIPTYLINE HCL 59 59 R 70 61
TRICOR 59 44 70 126
QUINAPRIL HCL 59 59 70 127
VYTORIN 57 51 73 195
PREDNISONE 56 55 74 43
PREMARIN 56 50 R 74 96
GEMFIBROZIL 55 54 76 88
PROPRANOLOL HCL 53 51 77 123
ISOSORBIDE MONONITRATE ER 51 49 78 62
RAMIPRIL 51 51 78 74
LANTUS 51 47 78 52
TRAMADOL HCL-ACETAMINOPHEN 50 50 81 194
CELEBREX 50 49 81 104
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Nov. 30, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.